Sophia Genetics Stock (NASDAQ: SOPH) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 57.256K |
Day Range | - - - |
52 Wk Range | 2.130 - 7.370 |
Market Cap | $340.220M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 47 |
Short Interest | 0.11% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Sophia Genetics (NASDAQ: SOPH) through any online brokerage.
Other companies in Sophia Genetics’s space includes: MultiPlan (NYSE:MPLN), OptimizeRx (NASDAQ:OPRX), GoodRx Holdings (NASDAQ:GDRX), Definitive Healthcare (NASDAQ:DH) and TruBridge (NASDAQ:TBRG).
The latest price target for Sophia Genetics (NASDAQ: SOPH) was reported by BTIG on Wednesday, March 6, 2024. The analyst firm set a price target for 8.00 expecting SOPH to rise to within 12 months (a possible 53.55% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Sophia Genetics (NASDAQ: SOPH) is $5.21 last updated March 28, 2024 at 9:25 AM EDT.
There are no upcoming dividends for Sophia Genetics.
Sophia Genetics’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Sophia Genetics.
Sophia Genetics is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.